Sandra Horning, Jeff Rumens for Endpoints #JPM19
Roche vet Sandra Horning jumps on biopharma board no. 3 — what’s that worth?
Sandra Horning is in high demand.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.